Bio-Rad Laboratories, Inc. (BIO)

470,55 +9,77 (+2,12%) Alla chiusura: 04:03PM EDT

Bio-Rad Laboratories, Inc.

1000 Alfred Nobel Drive
Hercules, CA 94547
United States
510 724 7000
https://www.bio-rad.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 8.200

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Norman D. Schwartz	Chairman, CEO & Pres	3,15M	26,13M	1950
Mr. Ilan Daskal	Exec. VP & CFO	1,18M	782,98k	1966
Dr. Andrew J. Last Ph.D.	Exec. VP & COO	1,54M	1,03M	1960
Mr. Michael Crowley	Exec. VP of Global Commercial Operations	974,94k	1,85M	1962
Ms. Dara Grantham Wright	Exec. VP & Pres of Clinical Diagnostics Group	1,06M	N/D	1976
Mr. Ajit Ramalingam	Sr. VP & Chief Accounting Officer	N/D	N/D	1973
Mr. Yong Chung	VP of Investor Relations	N/D	N/D	N/D
Mr. Timothy S. Ernst	Exec. VP, Gen. Counsel & Sec.	N/D	N/D	1960
Colleen Corey	Sr. VP of Global HR	N/D	N/D	N/D
Lee Boyd	Sr. VP of Global Commercial Operations - Asia Pacific	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2021 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Governance aziendale

L'ISS Governance QualityScore di Bio-Rad Laboratories, Inc. al 1 febbraio 2023 è 10. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 10; diritti degli azionisti: 10; retribuzione: 9.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.